Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week openlabel trial

被引：124
|
作者：
Haibel, H [1 ]
Rudwaleit, M
Brandt, HC
Grozdanovic, Z
Listing, J
Kupper, H
Braun, J
Sieper, J
机构：
[1] Klinikum Benjamin Franklin, D-12200 Berlin, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Abbott GmbH & Co, Ludwigshafen, Germany
[4] Ctr Rheumatol Ruhrgebiet, Herne, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 02期
关键词：
D O I：
10.1002/art.21563
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：678 / 681
页数：4
相关论文
共 50 条
  • [41] LONG TERM INHIBITION OF IL-17A WITH SECUKINUMAB REDUCES SPINAL INFLAMMATION BUT HAS NO INFLUENCE ON FATTY LESIONS AS ASSESSED BY MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Baraliakos, X.
    Braun, J.
    Laurent, D.
    Baeten, D.
    van der Heijde, D.
    Sieper, J.
    Emery, P.
    McInnes, I.
    van Laar, J.
    Landewe, R.
    Wordsworth, P.
    Wollenhaupt, J.
    Kellner, H.
    Wright, A.
    Vandenhende, F.
    Radford, K.
    Borah, B.
    Hueber, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 516 - 516
  • [42] Improvement of spinal inflammation in Ankylosing spondylitis (AS) by infliximab therapy as assessed by a magnetic resonance Imaging (MRI) using a novel evaluated spinal scoring system - Results of a double-blind placebo-controlled trial.
    Braun, J
    Baraliakos, X
    Golder, W
    Listing, J
    Brandt, J
    Bollow, M
    Sieper, J
    van der Heijde, D
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S426 - S427
  • [43] Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after two years of treatment with the anti-TNF agent infliximab
    Baraliakos, X
    Listing, J
    Brandt, J
    Rudwaleit, M
    Sieper, J
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 323 - 323
  • [44] Low-dose Infliximab (3 mg/kg) Significantly Reduces Spinal Inflammation on Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis: A Randomized Placebo-controlled Study
    Maksymowych, Walter P.
    Salonen, David
    Inman, Robert D.
    Rahman, Proton
    Lambert, Robert G. W.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1728 - 1734
  • [45] EFFECTS OF FILGOTINIB ON SPINAL LESIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: MAGNETIC RESONANCE IMAGING DATA FROM THE PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED TORTUGA TRIAL
    Maksymowych, W. P.
    Ostergaard, M.
    Landewe, R.
    Barchuk, W.
    Liu, K.
    Tasset, C.
    Gilles, L.
    Hendrikx, T.
    Besuyen, R.
    Baraliakos, X.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1227 - 1228
  • [46] Effects of Filgotinib on Spinal Lesions in Patients With Ankylosing Spondylitis: Magnetic Resonance Imaging Data from the Placebo-Controlled, Double-Blind, Randomized TORTUGA Trial
    Maksymowych, Walter
    Ostergaard, Mikkel
    Landewe, Robert
    Barchuk, William
    Liu, Ke
    Tasset, Chantal
    Gilles, Leen
    Hendrikx, Thijs
    Besuyen, Robin
    Baraliakos, Xenofon
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1120 - 1120
  • [47] Effects of Filgotinib on Spinal Lesions in Patients with Ankylosing Spondylitis: Magnetic Resonance Imaging Data from the Placebo-Controlled, Double-Blind, Randomized TORTUGA Trial
    Maksymowych, Walter
    Ostergaard, Mikkel
    Landewe, Robert
    Barchuk, William
    Liu, Ke
    Tasset, Chantal
    Gilles, Leen
    Hendrikx, Thijs
    Besuyen, Robin
    Baraliakos, Xenofon
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [48] Impact of Ustekinumab on Active Inflammation and Post-Inflammatory Structural Changes As Detected By Magnetic Resonance Imaging in Patients with Active Ankylosing Spondylitis: Results of a 28-Week, Prospective, Open-Label, Proof-of-Concept Study.
    Poddubnyy, Denis
    Hermann, Kay-Geert
    Callhoff, Johanna
    Listing, Joachim
    Sieper, Joachim
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1145 - S1145
  • [49] Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab -: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study
    Braun, J
    Landewé, R
    Hermann, KGA
    Han, J
    Yan, S
    Williamson, P
    van der Heijde, D
    ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1646 - 1652
  • [50] Secukinumab Significantly Improves Signs and Symptoms of Active Ankylosing Spondylitis: 52-Week Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial with Subcutaneous Loading and Maintenance Dosing
    Braun, Juergen
    Deodhar, Atul A.
    Sieper, Joachim
    Dougados, Maxime
    Porter, Brian
    Andersson, Mats
    Richards, Hanno
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345